000279886 001__ 279886
000279886 005__ 20250827141837.0
000279886 0247_ $$2doi$$a10.1111/jnc.70156
000279886 0247_ $$2pmid$$apmid:40653717
000279886 0247_ $$2ISSN$$a0022-3042
000279886 0247_ $$2ISSN$$a1471-4159
000279886 0247_ $$2altmetric$$aaltmetric:179480702
000279886 037__ $$aDZNE-2025-00853
000279886 041__ $$aEnglish
000279886 082__ $$a610
000279886 1001_ $$0P:(DE-2719)2814138$$aOuteiro, Tiago F$$b0$$eFirst author
000279886 245__ $$aPreface to the Special Issue 'History, Biology and Pathobiology of Prions: A Field of Renewed Hopes'.
000279886 260__ $$aOxford$$bWiley-Blackwell$$c2025
000279886 3367_ $$2DRIVER$$aarticle
000279886 3367_ $$2DataCite$$aOutput Types/Journal article
000279886 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1756297073_2231$$xEditorial
000279886 3367_ $$2BibTeX$$aARTICLE
000279886 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000279886 3367_ $$00$$2EndNote$$aJournal Article
000279886 520__ $$aResearch in the field of prion diseases has not only shed light on the mechanisms underlying transmissible spongiform encephalopathies (TSEs) but has also influenced the broader understanding of protein misfolding disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), and other tauopathies and synucleinopathies. Although prion diseases are rare and invariably fatal, they have provided an invaluable conceptual framework for the study of age-associated neurodegenerative disorders. On the occasion of the 'Prion 2023' meeting in Faro, Portugal, which brought together leading experts in prion biology and neurodegeneration to discuss emerging data and evolving concepts, we put together a special issue on the topic to discuss new structural insights, diagnostic technologies, and the increasing recognition of prion-like mechanisms in a wide range of proteinopathies. This Special Issue features six comprehensive review articles that highlight key advances and ongoing challenges in the study of prions and related disorders.
000279886 536__ $$0G:(DE-HGF)POF4-352$$a352 - Disease Mechanisms (POF4-352)$$cPOF4-352$$fPOF IV$$x0
000279886 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000279886 650_7 $$2Other$$aalpha‐synuclein
000279886 650_7 $$2Other$$aamyloid
000279886 650_7 $$2Other$$abeta‐amyloid
000279886 650_7 $$2Other$$acancer
000279886 650_7 $$2Other$$aneurodegeneration
000279886 650_7 $$2Other$$ap53
000279886 650_7 $$2Other$$aprion
000279886 650_7 $$2Other$$aprion diseases
000279886 650_7 $$2Other$$aprotein aggregation
000279886 650_7 $$2NLM Chemicals$$aPrions
000279886 650_2 $$2MeSH$$aHumans
000279886 650_2 $$2MeSH$$aPrion Diseases: pathology
000279886 650_2 $$2MeSH$$aPrion Diseases: metabolism
000279886 650_2 $$2MeSH$$aPrion Diseases: genetics
000279886 650_2 $$2MeSH$$aPrions: metabolism
000279886 650_2 $$2MeSH$$aAnimals
000279886 7001_ $$aVieira, Tuane C R G$$b1
000279886 773__ $$0PERI:(DE-600)2020528-4$$a10.1111/jnc.70156$$gVol. 169, no. 7, p. e70156$$n7$$pe70156$$tJournal of neurochemistry$$v169$$x0022-3042$$y2025
000279886 8564_ $$uhttps://pub.dzne.de/record/279886/files/DZNE-2025-00853_Restricted.pdf
000279886 8564_ $$uhttps://pub.dzne.de/record/279886/files/DZNE-2025-00853_Restricted.pdf?subformat=pdfa$$xpdfa
000279886 909CO $$ooai:pub.dzne.de:279886$$pVDB
000279886 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2814138$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000279886 9131_ $$0G:(DE-HGF)POF4-352$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Mechanisms$$x0
000279886 9141_ $$y2025
000279886 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2025-01-01$$wger
000279886 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2025-01-01$$wger
000279886 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ NEUROCHEM : 2022$$d2025-01-01
000279886 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-01
000279886 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-01
000279886 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-01
000279886 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-01
000279886 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-01
000279886 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-01-01
000279886 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-01
000279886 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2025-01-01
000279886 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-01-01
000279886 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-01
000279886 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-01
000279886 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2025-01-01
000279886 9201_ $$0I:(DE-2719)1410002$$kAG Fischer$$lEpigenetics and Systems Medicine in Neurodegenerative Diseases$$x0
000279886 980__ $$ajournal
000279886 980__ $$aVDB
000279886 980__ $$aI:(DE-2719)1410002
000279886 980__ $$aUNRESTRICTED